SEARCH

SEARCH BY CITATION

Literature Cited

  • Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML, Koseki H, Kitabayashi I. 2006. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 25: 39553965.
  • Bernardin F, Friedman AD. 2002. AML1 stimulates G1 to S progression via its transactivation domain. Oncogene 21: 32473252.
  • Bernardin F, Yang Y, Cleaves R, Zahurak M, Cheng L, Civin CI, Friedman AD. 2002. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res 62: 39043908.
  • Bernardin-Fried F, Kummalue T, Leijen S, Collector MI, Ravid K, Friedman AD. 2004. AML1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression. J Biol Chem 279: 1567815687.
  • Biggs JR, Zhang Y, Peterson LF, Garcia M, Zhang DE, Kraft AS. 2005. Phosphorylation of AML1/RUNX1 regulates its degradation and nuclear matrix association. Mol Cancer Res 3: 391401.
  • Biggs JR, Peterson LF, Zhang Y, Kraft AS, Zhang DE. 2006. AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex. Mol Cell Biol 26: 74207429.
  • Burel SA, Harakawa N, Zhou L, Pabst T, Tenen DG, Zhang DE. 2001. Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation. Mol Cell Biol 21: 55775590.
  • Burns CE, Traver D, Mayhall E, Shepard JL, Zon LI. 2005. Hematopoietic stem cell fate is established by the Notch–Runx pathway. Genes Dev 19: 23312342.
  • Cao W, Britos-Bray M, Claxton DF, Kelley CA, Speck NA, Liu PP, Friedman AD. 1997. CBFβ-SMMHC, expressed in M4eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle at the restriction point in myeloid and lymphoid cells. Oncogene 15: 13151327.
  • Cao W, Adya N, Britos-Bray M, Liu PP, Friedman AD. 1998. The Core binding factor a interaction domain and the smooth muscle myosin heavy chain segment of CBFβ-SMMHC are both required to slow cell proliferation. J Biol Chem 273: 3153431540.
  • Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. 2009. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature (in press).
  • D'Costa J, Chaudhuri S, Civin CI, Friedman AD. 2005. CBFβ-SMMHC slows proliferation of primary murine and human myeloid progenitors. Leukemia 19: 921929.
  • Delaney C, Varnum-Finney B, Aoyama K, Brashem-Stein C, Bernstein ID. 2005. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 106: 26932699.
  • Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, Goldfarb AN. 2003. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 101: 43334341.
  • Fleming HE, Janzen V, Lo Celso C, Guo J, Leahy KM, Kronenberg HM, Scadden DT. 2008. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2: 274283.
  • Friedman AD. 1999. Leukemogenesis by CBF oncoproteins. Leukemia 13: 19321942.
  • Fujita Y, Nishimura M, Taniwaki M, Abe T, Okuda T. 2001. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development. Biochem Biophys Res Commun 281: 12481255.
  • Galindo M, Pratap J, Young DW, Hovhannisyan H, Im HJ, Choi JY, Lian JB, Stein JL, Stein GS, van Wijnen AJ. 2005. The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J Biol Chem 280: 2027420285.
  • Ghozi MC, Bernstein Y, Negreanu V, Levanon D, Groner Y. 1996. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc Natl Acad Sci USA 93: 19351940.
  • Growney JD, Shigemastu H, Li Z, Lee BH, Adelspeerger J, Rowan R, Curley DP, Kutok JL, Akashi K, Williams IR, Speck NA, Gilliland DG. 2005. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106: 494504.
  • Guo H, Friedman AD. 2008. Phosphorylation of Runx1 by cyclin-dependent kinases regulates its interaction with HDAC1 and HDAC3. Blood 112: 495a.
  • Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Stavnezer J, Kawabata M, Miyazono K, Ito Y. 1999. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J Biol Chem 274: 3157731582.
  • Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, Yamagata T, Mitani K, Chiba S, Ogawa S, Kurokawa M, Hirai H. 2004. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 10: 299304.
  • Ichikawa M, Goyama S, Asai T, Kawazu M, Nakagawa M, Takeshita M, Chiba S, Ogawa S, Kurokawa M. 2008. AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis. J Immunol 18: 44024408.
  • Imai Y, Kurokawa M, Tanaka K, Friedman AD, Ogawa S, Mitani K, Yazaki Y, Hirai H. 1998. TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation. Biochem Biophys Res Commun 252: 582589.
  • Imai Y, Kurokawa M, Yamaguchi Y, Izutsu K, Nitta E, Mitani K, Satake M, Noda T, Ito Y, Hirai H. 2004. The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1. Mol Cell Biol 24: 10331043.
  • Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, Fukamachi H, Ito Y. 2008. RUNX3 attenuates β-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 14: 226237.
  • Jeannet G, Scheller M, Scarpellino L, Duboux S, Gardiol N, Back J, Kuttler F, Malanchi I, Birchmeier W, Leutz A, Huelsken J, Held W. 2008. Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin. Blood 111: 142149.
  • Kagoshima H, Sawa H, Mitani S, Bürglin TR, Shigesada K, Kohara Y. 2005. The C. elegans RUNX transcription factor RNT-1/MAB-2 is required for asymmetrical cell division of the T blast cell. Dev Biol 287: 262273.
  • Kagoshima H, Nimmo R, Saad N, Tanaka J, Miwa Y, Mitani S, Kohara Y, Woollard A. 2007. The C. elegans CBFβ homologue BRO-1 interacts with the Runx factor, RNT-1, to promote stem cell proliferation and self-renewal. Development 134: 39053915.
  • Kahler RA, Westendorf JJ. 2003. Lymphoid enhancer factor-1 and β-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 278: 1193711944.
  • Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, Satake M, Ito Y, Shigesada K. 1990. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. Mol Cell Biol 64: 48084819.
  • Kirstetter P, Anderson K, Porse BT, Jacobsen SE, Nerlov C. 2006. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol 7: 10481056.
  • Koch U, Wilson A, Cobas M, Kemler R, Macdonald HR, Radtke F. 2008. Simultaneous loss of β- and γ-catenin does not perturb hematopoiesis or lymphopoiesis. Blood 111: 160164.
  • Kummalue T, Lou J, Friedman AD. 2002. Multimerization via its myosin domain is a prerequisite for inhibition of CBF activities by the CBFβ-SMMHC myeloid leukemia oncoprotein. Mol Cell Biol 22: 82788291.
  • Landry JR, Kinston S, Knezevic K, de Bruijn MF, Wilson N, Nottingham WT, Peitz M, Edenhofer F, Pimanda JE, Ottersbach K, Göttgens B. 2008. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver. Blood 111: 30053014.
  • Lavoie JN, L'Allemain G, Brunet A, Müller R, Pouysségur J. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271: 2060820616.
  • Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K, Murray HL, Zucker JP, Yuan B, Bell GW, Herbolsheimer E, Hannett NM, Sun K, Odom DT, Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, Young RA. 2006. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301313.
  • Levanon D, Glusman G, Bangsow T, Ben-Asher E, Male DA, Avidan N, Bangsow C, Hattori M, Taylor TD, Taudien S, Blechschmidt K, Shimizu N, Rosenthal A, Sakaki Y, Lancet D, Groner Y. 2001. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene 262: 2333.
  • Liu H, Carlsson L, Grundström T. 2006. Identification of an N-terminal transactivation domain of Runx1 that separates molecular function from global differentiation function. J Biol Chem 281: 2565925669.
  • Lou J, Cao W, Bernardin F, Ayyanathan K, Rauscher FJ III, Friedman AD. 2000. Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF—a model for overcoming inhibition of proliferation by CBF oncoproteins. Oncogene 19: 26952703.
  • Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW. 2000. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem 275: 651656.
  • Maillard I, Koch U, Dumortier A, Shestova O, Xu L, Sai H, Pross SE, Aster JC, Bhandoola A, Radtke F, Pear WS. 2008. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2: 356366.
  • Mao S, Frank RC, Zhang J, Miyazaki Y, Nimer SD. 1999. Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias. Mol Cell Biol 19: 36353644.
  • Mayall TP, Sheridan PL, Montminy MR, Jones KA. 1997. Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev 11: 887899.
  • Meyers S, Downing JR, Hiebert SW. 1993. Identification of AML1 and the (8;21) translocation protein AML1-ETO as sequence specific DNA binding proteins: the runt homology domain is required for DNA binding and protein–protein interactions. Mol Cell Biol 13: 63366345.
  • Mikhail FM, Serry KA, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM, Coignet L, Nucifora G. 2002. AML1 gene over-expression in childhood acute lymphoblastic leukemia. Leukemia 16: 658668.
  • Miyoshi H, Ohira M, Shimizu K, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E, Ohki M. 1995. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucl Acids Res 23: 27622769.
  • Nakagawa M, Ichikawa M, Kumano K, Goyama S, Kawazu M, Asai T, Ogawa S, Kurokawa M, Chiba S. 2006. AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis. Blood 108: 33293334.
  • Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S. 2000. AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia. Haematologica 85: 362366.
  • Nimmo R, Antebi A, Woollard A. 2005. mab-2 encodes RNT-1, a C. elegans Runx homologue essential for controlling cell proliferation in a stem cell-like developmental lineage. Development 132: 50435054.
  • North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M, Marín-Padilla M, Speck NA. 1999. Development. 126: 25632575.
  • North TE, de Bruijn MF, Stacy T, Talebian L, Lind E, Robin C, Binder M, Dzierzak E, Speck NA. 2002. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 16: 661672.
  • North TE, Stacy T, Matheny CJ, Speck NA, de Bruijn MF. 2004. Runx1 is expressed in adult mouse hematopoietic stem cells and differentiating myeloid and lymphoid cells, but not in maturing erythroid cells. Stem Cells 22: 158168.
  • Nottingham WT, Jarratt A, Burgess M, Speck CL, Cheng JF, Prabhakar S, Rubin EM, Li PS, Sloane-Stanley J, Kong-A-San J, de Bruijn MF. 2007. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood 110: 41884197.
  • Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S, Friedman AD. 1994. PEBP2/CBF, the murine homolog of the human myeloid proto-oncogenes AML1 and PEBP2β/CBFβ, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 14: 55585568.
  • Ogawa E, Inuzuka M, Maruamna M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K. 1993. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 194: 314331.
  • Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. 1996. AML-1, the target of multiple chromosomal translocations in human leukemia, is essential for normal murine fetal hematopoiesis. Cell 84: 321330.
  • Penther D, Preudhomme C, Talmant P, Roumier C, Godon A, Méchinaud F, Milpied N, Bataille R, Avet-Loiseau H. 2002. Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation. Leukemia 16: 11311134.
  • Peterson LF, Boyapati A, Ranganathan V, Iwama A, Tenen DG, Tsai S, Zhang DE. 2005. The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3. Mol Cell Biol 25: 1020510219.
  • Pimanda JE, Donaldson IJ, de Bruijn MF, Kinston S, Knezevic K, Huckle L, Piltz S, Landry JR, Green AR, Tannahill D, Göttgens B. 2007. The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity. Proc Natl Acad Sci USA 104: 840845.
  • Pozner A, Lotem J, Xiao C, Goldenberg D, Brenner O, Negreanu V, Levanon D, Groner Y. 2007. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis. BMC Dev Biol 7: 84.
  • Qiao M, Shapiro P, Fosbrink M, Rus H, Kumar R, Passaniti A. 2006. Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation. J Biol Chem 281: 71187128.
  • Redondo JM, Pfohl JL, Hernandez-Munain C, Wang S, Speck NA, Krangel MS. 1992. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. Mol Cell Biol 12: 48174823.
  • Reed-Inderbitzin E, Moreno-Miralles I, Vanden-Eynden SK, Xie J, Lutterbach B, Durst-Goodwin KL, Luce KS, Irvin BJ, Cleary ML, Brandt SJ, Hiebert SW. 2006. RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription. Oncogene 25: 57775786.
  • Reinhold MI, Naski MC. 2007. Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J Biol Chem 28: 36533663.
  • Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL. 2003. A role for Wnt signaling in self-renewal of haematopoietic stem cells. Nature 423: 409414.
  • Robertson AJ, Coluccio A, Knowlton P, Dickey-Sims C, Coffman JA. 2008. Runx expression is mitogenic and mutually linked to Wnt activity in blastula-stage sea urchin embryos. PLoS ONE 3: e3770.
  • Scheller M, Huelsken J, Rosenbauer F, Taketo MM, Birchmeier W, Tenen DG, Leutz A. 2006. Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation. Nat Immunol 7: 10371047.
  • Spender LC, Whiteman HJ, Karstegl CE, Farrell PJ. 2005. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene 24: 18731881.
  • Strom DK, Nip J, Westendorf JJ, Linggi B, Lutterbach B, Downing JR, Lenny N, Hiebert SW. 2000. Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle. J Biol Chem 275: 34383445.
  • Sun W, Graves BJ, Speck NA. 1995. Transactivation of the moloney murine leukemia virus and T-cell receptor β-chain enhancers by CBF and Ets requires intact binding sites for both proteins. J Virol 69: 49414949.
  • Suzow JG, Friedman AD. 1993. The murine myeloperoxidase promoter contains multiple functional elements—one element binds a cell type-restricted transcription factor, myeloid nuclear factor 1(MyNF1). Mol Cell Biol 13: 21412151.
  • Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111: 621633.
  • Teplyuk NM, Galindo M, Teplyuk VI, Pratap J, Young DW, Lapointe D, Javed A, Stein JL, Lian JB, Stein GS, van Wijnen AJ. 2008. Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors. J Biol Chem 283: 2758527597.
  • Tsuzuki S, Hong D, Gupta R, Matsuo K, Seto M, Enver T. 2007. Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1. PLoS Med 4: e172.
  • Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13: 33243339.
  • Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 93: 34443449.
  • Wang S, Zhang Y, Soosairajah J, Kraft AS. 2007. Regulation of RUNX1/AML1 during the G2/M transition. Leuk Res 31: 839851.
  • Wee HJ, Huang G, Shigesada K, Ito Y. 2002. Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms. EMBO Reports 3: 967974.
  • Wee HJ, Voon DC, Bae SC, Ito Y. 2008. PEBP2β/CBFβ-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis. Blood 112: 37773787.
  • Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. 1999. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J 18: 25512562.
  • Yang Y, Wang W, Cleaves R, Zahurak M, Cheng L, Civin CI, Friedman AD. 2002. Acceleration of G1 cooperates with CBFβ-SMMHC to induce acute leukemia in mice. Cancer Res 62: 22322235.
  • Yokomizo T, Ogawa M, Osato M, Kanno T, Yoshida H, Fujimoto T, Fraser S, Nishikawa S, Okada H, Satake M, Noda T, Nishikawa S, Ito Y. 2001. Requirement of Runx1/AML1/PEBP2αB for the generation of haematopoietic cells from endothelial cells. Genes Cells 6: 1323.
  • Young DW, Hassan MQ, Pratap J, Galindo M, Zaidi SK, Lee SH, Yang X, Xie R, Javed A, Underwood JM, Furcinitti P, Imbalzano AN, Penman S, Nickerson JA, Montecino MA, Lian JB, Stein JL, van Wijnen AJ, Stein GS. 2007. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 445: 442446.
  • Zambidis ET, Peault B, Park TS, Bunz F, Civin CI. 2005. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 106: 860870.
  • Zhang DE, Fujioka K, Hetherington CJ, Shapiro LH, Chen HM, Look AT, Tenen DG. 1994. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol 14: 80858095.
  • Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CL, Chen HM, Hiebert SW, Tenen DG. 1996. CCAAT enhancer binding protein and AML1 synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol 16: 12311240.
  • Zhang L, Fried F, Guo H, Friedman AD. 2008. Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. Blood 111: 11931200.
  • Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, Lagoo A, Reya T. 2007. Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12: 528541.
  • Zhao X, Jankovic V, Gural A, Huang G, Pardanani A, Menendez S, Zhang J, Dunne R, Xiao A, Erdjument-Bromage H, Allis CD, Tempst P, Nimer SD. 2008. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 22: 640653.